Leaflet LANVIS 40mg tablets
Indicated for: cancer
Route of administration: oral
Substance: thioguanine (antineoplastic agent)
ATC: L01BB03 (Antineoplastic and immunomodulating agents | Antimetabolites | Purine analogues)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Thioguanine is an antimetabolite agent used in the treatment of acute leukemia and other hematologic cancers. It works by interfering with DNA and RNA synthesis in cancer cells, thereby inhibiting their growth and division.
The medication is taken orally, usually once daily, as directed by a doctor. The dosage is adjusted based on the patient's weight, clinical condition, and response to treatment.
Patients should be closely monitored to detect potential side effects, such as bone marrow suppression, nausea, or liver toxicity. It is important for patients to inform their doctor of any unusual symptoms.
Common side effects include nausea, vomiting, decreased blood cell counts, and elevated liver enzymes. In rare cases, severe reactions such as hepatotoxicity or serious infections may occur. Patients should be informed of these risks before starting treatment.
General data about LANVIS 40mg
- Substance: thioguanine
- Date of latest medicines list: 01-06-2026
- Product code: W58869001
- Concentration: 40mg
- Pharmaceutical form: tablets
- Quantity: 25
- Product type: Original
- Price: 485.65 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.